<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Physiol Anthropol</journal-id><journal-id journal-id-type="iso-abbrev">J Physiol Anthropol</journal-id><journal-title-group><journal-title>Journal of Physiological Anthropology</journal-title></journal-title-group><issn pub-type="ppub">1880-6791</issn><issn pub-type="epub">1880-6805</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31488191</article-id><article-id pub-id-type="pmc">6729028</article-id><article-id pub-id-type="publisher-id">204</article-id><article-id pub-id-type="doi">10.1186/s40101-019-0204-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Longevity-associated mitochondrial DNA 5178 C/A polymorphism modifies effect of aging on renal function in male Japanese health checkup examinees: an exploratory cross-sectional study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ohtsu</surname><given-names>Iichiro</given-names></name><address><email>showa11104018@yahoo.co.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ishikawa</surname><given-names>Mamoru</given-names></name><address><email>mamoru.ishikawa@achs.jp</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Matsunaga</surname><given-names>Naomi</given-names></name><address><email>naomim@ks.kyorin-u.ac.jp</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Karita</surname><given-names>Kanae</given-names></name><address><email>kanae@ks.kyorin-u.ac.jp</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yoshida</surname><given-names>Masao</given-names></name><address><email>yohhy@ks.kyorin-u.ac.jp</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ochiai</surname><given-names>Hirotaka</given-names></name><address><email>h-ochiai@med.showa-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shirasawa</surname><given-names>Takako</given-names></name><address><email>shirasawa@med.showa-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Yoshimoto</surname><given-names>Takahiko</given-names></name><address><email>yoshimotot@med.showa-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Minoura</surname><given-names>Akira</given-names></name><address><email>minoaki@med.showa-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sai</surname><given-names>Shogo</given-names></name><address><email>sai@cmed.showa-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2252-3542</contrib-id><name><surname>Kokaze</surname><given-names>Akatsuki</given-names></name><address><phone>+81(3)3784-8133</phone><email>akokaze@med.showa-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8864 3422</institution-id><institution-id institution-id-type="GRID">grid.410714.7</institution-id><institution>Department of Hygiene, Public Health and Preventive Medicine, </institution><institution>Showa University School of Medicine, </institution></institution-wrap>1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9340 2869</institution-id><institution-id institution-id-type="GRID">grid.411205.3</institution-id><institution>Department of Public Health, </institution><institution>Kyorin University School of Medicine, </institution></institution-wrap>6-20-2 Shinkawa, Mitaka-shi, Tokyo, 181-8611 Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0418 6260</institution-id><institution-id institution-id-type="GRID">grid.415974.a</institution-id><institution>Mito Red Cross Hospital, </institution></institution-wrap>3-12-48 Sannomaru, Mito-shi, Ibaraki, 310-0011 Japan </aff></contrib-group><pub-date pub-type="epub"><day>5</day><month>9</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>5</day><month>9</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>38</volume><elocation-id>12</elocation-id><history><date date-type="received"><day>21</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>27</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Mitochondrial DNA 5178 (Mt5178) C/A polymorphism is reportedly associated with longevity in the Japanese population. The objective of this study was to investigate whether Mt5178 C/A polymorphism influences the effect of physiological aging on renal function in male Japanese health checkup examinees.</p></sec><sec><title>Methods</title><p id="Par2">A total of 404 male subjects (mean age &#x000b1; SD, 53.9 &#x000b1; 7.8&#x02009;years; range, 29&#x02013;76&#x02009;years) were selected from among individuals visiting the hospital for regular medical checkups. After Mt5178 C/A genotyping, a cross-sectional study assessing the joint effects of Mt5178 C/A polymorphism and aging on renal function was then conducted. Renal function was evaluated by estimated glomerular filtration rate (eGFR). Subjects were divided into three age groups (&#x0003c;&#x02009;50, 50&#x02013;59, &#x02265;&#x02009;60&#x02009;years).</p></sec><sec><title>Results</title><p id="Par3">In simple linear regression analysis, a significant negative association between aging and eGFR was observed in both Mt5178C and Mt5178A genotypic men (<italic>P</italic> &#x0003c; 0.001 and <italic>P</italic> = 0.003, respectively). However, in multiple linear regression analysis, a significant effect of aging on reduced eGFR was observed only in Mt5178C genotypic men (<italic>P</italic> &#x0003c; 0.001). Logistic regression analysis showed that, in the case of reduced eGFR defined as &#x0003c;&#x02009;75&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>, reduced eGFR was dependent on aging in both Mt5178C and Mt5178A genotypic men (<italic>P</italic> for trend &#x0003c;&#x02009;0.001 and <italic>P</italic> for trend = 0.002, respectively). After adjusting for smoking status and alcohol consumption, reduced eGFR was also dependent on aging in both Mt5178C and Mt5178A genotypic men (<italic>P</italic> for trend &#x0003c;&#x02009;0.001 and <italic>P</italic> for trend = 0.014, respectively). However, in reduced eGFR defined as &#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>, reduced eGFR was dependent on aging only in Mt5178C genotypic men (<italic>P</italic> for trend &#x0003c;&#x02009;0.001).</p></sec><sec><title>Conclusions</title><p id="Par4">This cross-sectional study suggests that Mt5178 C/A polymorphism modulates the effects of physiological aging on kidney function in Japanese men.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Estimated glomerular filtration rate</kwd><kwd>Kidney function</kwd><kwd>Longevity</kwd><kwd>Mitochondrial DNA polymorphism</kwd><kwd>NADH dehydrogenase</kwd><kwd>Physiological aging</kwd></kwd-group><funding-group><award-group><funding-source><institution>Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan </institution></funding-source><award-id>Nos. 14570355, 18590572, 23500859, and 26350908</award-id><principal-award-recipient><name><surname>Kokaze</surname><given-names>Akatsuki</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par17">Physiological aging, even in healthy aging, is associated with changes in kidney function, for example, glomerular filtration rate (GFR), sodium resorption, transtubular potassium gradient, urinary concentration, renal vascular resistance, and plasma flow [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. Among these physiological changes, a decline in GFR with normal aging is widely known [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>].</p><p id="Par18">The mitochondria play a key role not only in aging [<xref ref-type="bibr" rid="CR4">4</xref>] but also in inherited and acquired kidney diseases [<xref ref-type="bibr" rid="CR5">5</xref>]. Higher mitochondrial DNA copy number in peripheral blood is associated with a lower risk of incident chronic kidney disease (CKD) [<xref ref-type="bibr" rid="CR6">6</xref>]. Moreover, several mitochondrial DNA polymorphisms are reportedly associated with renal diseases [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Mitochondrial DNA 5178 (Mt5178) C/A polymorphism, which is also recognized as NADH dehydrogenase subunit-2 237 (ND2-237) Leu/Met polymorphism, is originally reported to be associated with longevity in the Japanese population [<xref ref-type="bibr" rid="CR9">9</xref>]. The frequency of Mt5178A genotype is significantly higher in Japanese centenarians than in the general population [<xref ref-type="bibr" rid="CR9">9</xref>]. Several clinical epidemiological studies reported that Japanese individuals with Mt5178A genotype are more resistant to adult-onset diseases than those with Mt5178C genotype [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. Moreover, our previous research reported that Mt5178 C/A polymorphism modulates the effect of alcohol consumption [<xref ref-type="bibr" rid="CR15">15</xref>] or green tea consumption [<xref ref-type="bibr" rid="CR16">16</xref>] on renal function, evaluated by estimated GFR (eGFR). Although an association between Mt5178 C/A polymorphism and physiological aging effect on pulmonary function was reported [<xref ref-type="bibr" rid="CR17">17</xref>], an association between Mt5178 C/A polymorphism and effect of physiological aging on kidney function has not yet been reported.</p><p id="Par19">The objective of this exploratory cross-sectional study is to investigate whether Mt5178 C/A polymorphism modifies the effect of physiological aging on renal function.</p></sec><sec id="Sec2"><title>Subjects and methods</title><sec id="Sec3"><title>Study subjects</title><p id="Par20">Study subjects were recruited from among individuals visiting the Mito Red Cross Hospital for regular medical checkups between August 1999 and August 2000. This study was conducted in accordance with the Declaration of Helsinki. The Ethics Committee of Kyorin University School of Medicine approved the study protocol. Written informed consent was obtained from 602 volunteers before participation. Because of the insufficient number of women available for classification into groups based on Mt5178 C/A genotype and age, female health checkup examinees were excluded. Diabetic patients undergoing treatment were also excluded. Moreover, male health checkup examinees with unclear data were excluded. Finally, 404 Japanese men (mean age &#x000b1; SD, 53.9 &#x000b1; 7.8&#x02009;years; range, 29&#x02013;76&#x02009;years) were included in the analysis.</p></sec><sec id="Sec4"><title>Anthropometric and clinical characteristics of subjects</title><p id="Par21">Subjects&#x02019; data on age, height, weight, blood pressure, serum lipid level, fasting plasma glucose level, serum uric acid level, blood urea nitrogen (BUN) level, and serum creatinine level were collected from the results of regular medical checkups. Renal function was evaluated by eGFR. The eGFR value was calculated using a three-variable Japanese equation: eGFR = 194 &#x000d7; creatinine<sup>&#x02212;1.094</sup> &#x000d7; age<sup>&#x02212;0.287</sup> [<xref ref-type="bibr" rid="CR18">18</xref>]. Body mass index (BMI), which is reported to be associated with eGFR [<xref ref-type="bibr" rid="CR19">19</xref>], was defined as the ratio of subject weight (kg) to the square of subject height (m<sup>2</sup>). Information on antihypertensive medication, which is reportedly associated with kidney function [<xref ref-type="bibr" rid="CR20">20</xref>], was derived from the subjects&#x02019; health records. For antihypertensive medication use, subjects were classified as taking no drug treatment or taking medicine. A survey of habitual smoking, alcohol consumption, and green tea consumption was performed by means of a questionnaire. Smoking status was classified based on the number of cigarettes smoked per day (never- or ex-smokers, 1&#x02013;20 cigarettes smoked per day, and &#x02265;&#x02009;21 cigarettes smoked per day). Alcohol consumption was classified based on drinking frequency (non- or ex-drinkers; occasional drinkers, which included those who drink several times per week or per month; and daily drinkers). Green tea consumption was classified based on the number of cups of green tea per day (&#x02264;&#x02009;1 cup per day, 2&#x02013;3 cups per day, 4&#x02013;5 cups per day, and &#x02265;&#x02009;6 cups per day). Selection of these lifestyle habits was based on previous research [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec5"><title>Genotyping</title><p id="Par22">Mt5178 genotyping methods have been described previously [<xref ref-type="bibr" rid="CR22">22</xref>]. Briefly, DNA was extracted from white blood cells. Mt5178 C/A genotype was determined using the polymerase chain reaction-restriction fragment length polymorphism test. The absence or presence of an <italic>Alu</italic>I site was designated as Mt5178A or Mt5178C, respectively.</p></sec><sec id="Sec6"><title>Statistical analyses</title><p id="Par23">All statistical analyses were performed using SAS statistical software (version 9.4 for Windows; SAS Institute, Inc., Cary, NC, USA). Based on a large-scale cross-sectional study of CKD in Japanese adults undergoing an annual health checkup [<xref ref-type="bibr" rid="CR23">23</xref>], subjects were divided into three age groups (&#x0003c;&#x02009;50, 50&#x02013;59, and &#x02265;&#x02009;60&#x02009;years). Multiple logistic regression analysis was conducted to calculate odds ratios (ORs) for the risk of reduced eGFR. Reduced eGFR was defined as &#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup> [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>] or &#x0003c;&#x02009;75&#x02009;mL/min/1.73&#x02009;m<sup>2</sup> [<xref ref-type="bibr" rid="CR27">27</xref>]. For simple and multiple linear regression analyses, age&#x02009;(&#x0003c;&#x02009;50&#x02009;years = 1, 50&#x02013;59&#x02009;years = 2, &#x02265;&#x02009;60&#x02009;years = 3), habitual smoking (never- or ex-smokers = 0, 1&#x02013;20 cigarettes smoked per day = 1, &#x02265;&#x02009;21 cigarettes smoked per day = 2), alcohol consumption (non- or ex-drinkers = 0, occasional drinkers = 1, daily drinkers = 2), green tea consumption (&#x02264;&#x02009;1 cup per day = 1, 2&#x02013;3 cups per day = 2, 4&#x02013;5 cups per day = 3, &#x02265;&#x02009;6 cups per day = 4), and antihypertensive treatment (not receiving antihypertensive treatment = 0, receiving antihypertensive treatment = 1) were numerically coded. Multicollinearity of independent variables was statistically tested using variance inflation factor values. For the multiple logistic regression analysis, the abovementioned numerical codes were also used. In the final multiple logistic regression model, only independent variables that reached <italic>P</italic> &#x0003c; 0.05 in the simple linear regression model were included. Differences with <italic>P</italic> values &#x0003c;&#x02009;0.05 were considered to be statistically significant.</p></sec></sec><sec id="Sec7"><title>Results</title><p id="Par24">No significant differences in anthropometric or clinical characteristics, including BUN levels, serum creatinine levels, or eGFR, were observed between Mt5178C and Mt5178A genotypes (Table <xref rid="Tab1" ref-type="table">1</xref>). The prevalence of eGFR of &#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup> was 82.4% in Mt5178C genotypic men and 75.2% in Mt5178A genotypic men, prevalence of eGFR of &#x0003c;&#x02009;75&#x02009;mL/min/1.73&#x02009;m<sup>2</sup> was 40.5% in Mt5178C genotypic men and 33.2% in Mt5178A genotypic men. The prevalence of moderately decreased eGFR of &#x0003c;&#x02009;60&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>, generally defined as CKD, was 4.5% in Mt5178C genotypic men and 2.6% in Mt5178A genotypic men. The chi-squared test indicated no significant differences in renal function evaluated by eGFR. Furthermore, there were no significant differences in antihypertensive medications, habitual smoking, alcohol consumption, or green tea consumption between Mt5178 C/A genotypes.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Anthropometric and clinical characteristics of study subjects by Mt5178 C/A genotype</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Mt5178C, <italic>N</italic> = 247</th><th>Mt5178A, <italic>N</italic> = 157</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>Age (years)*</td><td>54.4 (7.8)</td><td>53.2 (7.8)</td><td>0.142</td></tr><tr><td>Body mass index (kg/m<sup>2</sup>)*</td><td>23.3 (2.8)</td><td>23.5 (2.6)</td><td>0.366</td></tr><tr><td>Systolic blood pressure (mmHg)*</td><td>125.8 (15.8)</td><td>125.7 (14.1)</td><td>0.934</td></tr><tr><td>Diastolic blood pressure (mmHg)**</td><td>73.9 (10.6)</td><td>73.7 (9.1)</td><td>0.817</td></tr><tr><td>LDL cholesterol (mg/dL)*</td><td>121.3 (34.4)</td><td>118.0 (30.8)</td><td>0.319</td></tr><tr><td>HDL cholesterol (mg/dL)**</td><td>54.5 (13.5)</td><td>56.2 (16.1)</td><td>0.285</td></tr><tr><td>Triglyceride (mg/dL)*</td><td>137.4 (91.2)</td><td>139.4 (90.2)</td><td>0.826</td></tr><tr><td>Fasting plasma glucose (mg/dL)**</td><td>99.7 (18.9)</td><td>98.2 (11.0)</td><td>0.334</td></tr><tr><td>Uric acid (mg/dL)*</td><td>5.94 (1.24)</td><td>5.94 (1.22)</td><td>0.970</td></tr><tr><td>Blood urea nitrogen (mg/dL)*</td><td>15.8 (3.7)</td><td>15.3 (3.4)</td><td>0.157</td></tr><tr><td>Creatinine (mg/dL)*</td><td>0.813 (0.118)</td><td>0.798 (0.111)</td><td>0.187</td></tr><tr><td>Estimated glomerular filtration rate (eGFR; mL/min/1.73&#x02009;m<sup>2</sup>)*</td><td>79.5 (13.6)</td><td>81.4 (12.4)</td><td>0.157</td></tr><tr><td>Renal function (&#x02265;&#x02009;90/75&#x02013;90/60&#x02013;75/&#x0003c;&#x02009;60) (%)***</td><td>18.6/40.9/36.0/4.5</td><td>24.8/42.0/30.6/2.6</td><td>0.311</td></tr><tr><td>Smoking status (never- or ex-smoker/1&#x02013;20 cigarettes per day/&#x02265;&#x02009;21 cigarettes per day) (%)***</td><td>59.1/29.2/11.7</td><td>59.2/25.5/15.3</td><td>0.500</td></tr><tr><td>Alcohol consumption (non- or ex-drinker/occasionally/daily) (%)***</td><td>18.2/35.2/46.6</td><td>13.4/38.2/48.4</td><td>0.431</td></tr><tr><td>Green tea consumption (&#x02264;&#x02009;1 cup per day/2&#x02013;3 cups per day/4&#x02013;5 cups per day/&#x02265;&#x02009;6 cups per day) (%)***</td><td>26.3/30.3/21.9/21.5</td><td>28.0/33.8/17.7/18.5</td><td>0.782</td></tr><tr><td>Antihypertensive medication (%)***</td><td>19.4</td><td>13.4</td><td>0.115</td></tr></tbody></table><table-wrap-foot><p>Age, body mass index, systolic blood pressure, diastolic blood pressure, LDL cholesterol levels, HDL cholesterol levels, triglyceride levels, fasting plasma glucose levels, uric acid levels, blood urea nitrogen levels, creatinine levels, and eGFR are given as means (SD). All <italic>P</italic> values depict significant differences between Mt5178C and Mt5178A genotypic men</p><p>*Student&#x02019;s <italic>t</italic> test, **Welch&#x02019;s <italic>t</italic> test, ***Chi-squared test</p></table-wrap-foot></table-wrap></p><p id="Par25">In simple linear regression analysis, age was significantly and positively associated with BUN level in both Mt5178C and Mt5178A genotypic men (<italic>P</italic> = 0.015 and <italic>P</italic> &#x0003c; 0.001, respectively) (Table <xref rid="Tab2" ref-type="table">2</xref>). Alcohol consumption was significantly and negatively associated with serum creatinine level only in Mt5178A genotypic men (<italic>P</italic> = 0.048). Age was significantly and negatively associated with eGFR in both Mt5178C and Mt5178A genotypic men (<italic>P</italic> &#x0003c; 0.001 and <italic>P</italic> = 0.003, respectively). Smoking status and alcohol consumption were significantly and positively associated with eGFR only in Mt5178A genotypic men (<italic>P</italic> = 0.043 and <italic>P</italic> = 0.004, respectively). Multiple linear regression analysis indicated that variance inflation factor values showed low collinearity for all independent variables. In multiple linear regression analysis, age was also significantly and positively associated with BUN level in both Mt5178C and Mt5178A genotypic men (<italic>P</italic> = 0.038 and <italic>P</italic> &#x0003c; 0.001, respectively). Age was significantly and negatively associated with eGFR only in Mt5178C genotypic men (<italic>P</italic> &#x0003c; 0.001). Alcohol consumption was significantly and positively associated with eGFR only in Mt5178A genotypic men (<italic>P</italic> = 0.010).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Simple and multiple linear regression models for blood urea nitrogen, creatinine, and estimated glomerular filtration rate by Mt5178 C/A genotype</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="11">Simple linear regression model</td></tr><tr><td rowspan="2"/><td colspan="3">Blood urea nitrogen</td><td colspan="3">Creatinine</td><td colspan="3">Estimated glomerular filtration rate</td><td/></tr><tr><td>Regression coefficient</td><td>Standard error</td><td><italic>P</italic> value</td><td>Regression coefficient</td><td>Standard error</td><td><italic>P</italic> value</td><td>Regression coefficient</td><td>Standard error</td><td><italic>P</italic> value</td><td/></tr><tr><td colspan="11">&#x02003;Mt5178C</td></tr><tr><td>&#x02003;&#x02003;Age</td><td>0.806</td><td>0.329</td><td>0.015</td><td>0.018</td><td>0.010</td><td>0.087</td><td>&#x02212;&#x02009;5.900</td><td>1.159</td><td>&#x0003c;&#x02009;0.001</td><td/></tr><tr><td>&#x02003;&#x02003;Body mass index</td><td>&#x02212;&#x02009;0.084</td><td>0.085</td><td>0.324</td><td>0.003</td><td>0.003</td><td>0.241</td><td>&#x02212;&#x02009;0.274</td><td>0.312</td><td>0.381</td><td/></tr><tr><td>&#x02003;&#x02003;Smoking status</td><td>&#x02212;&#x02009;0.623</td><td>0.338</td><td>0.067</td><td>&#x02212;&#x02009;0.004</td><td>0.011</td><td>0.705</td><td>1.113</td><td>1.244</td><td>0.372</td><td/></tr><tr><td>&#x02003;&#x02003;Alcohol consumption</td><td>&#x02212;&#x02009;0.029</td><td>0.315</td><td>0.925</td><td>&#x02212;&#x02009;0.004</td><td>0.010</td><td>0.705</td><td>0.791</td><td>1.150</td><td>0.492</td><td/></tr><tr><td>&#x02003;&#x02003;Green tea consumption</td><td>0.216</td><td>0.217</td><td>0.320</td><td>0.004</td><td>0.007</td><td>0.546</td><td>&#x02212;&#x02009;1.281</td><td>0.790</td><td>0.106</td><td/></tr><tr><td>&#x02003;&#x02003;Antihypertensive medication</td><td>&#x02212;&#x02009;0.313</td><td>0.598</td><td>0.601</td><td>0.015</td><td>0.019</td><td>0.433</td><td>&#x02212;&#x02009;2.565</td><td>2.186</td><td>0.242</td><td/></tr><tr><td colspan="11">&#x02003;Mt5178A</td></tr><tr><td>&#x02003;&#x02003;Age</td><td>1.229</td><td>0.342</td><td>&#x0003c;&#x02009;0.001</td><td>&#x02212;&#x02009;0.001</td><td>0.012</td><td>0.956</td><td>&#x02212;&#x02009;3.877</td><td>1.273</td><td>0.003</td><td/></tr><tr><td>&#x02003;&#x02003;Body mass index</td><td>0.034</td><td>0.103</td><td>0.745</td><td>0.002</td><td>0.003</td><td>0.549</td><td>&#x02212;&#x02009;0.224</td><td>0.379</td><td>0.555</td><td/></tr><tr><td>&#x02003;&#x02003;Smoking status</td><td>&#x02212;&#x02009;0.582</td><td>0.360</td><td>0.109</td><td>&#x02212;&#x02009;0.021</td><td>0.012</td><td>0.075</td><td>2.694</td><td>1.320</td><td>0.043</td><td/></tr><tr><td>&#x02003;&#x02003;Alcohol consumption</td><td>&#x02212;&#x02009;0.180</td><td>0.383</td><td>0.639</td><td>&#x02212;&#x02009;0.025</td><td>0.012</td><td>0.048</td><td>3.996</td><td>1.376</td><td>0.004</td><td/></tr><tr><td>&#x02003;&#x02003;Green tea consumption</td><td>&#x02212;&#x02009;0.014</td><td>0.253</td><td>0.957</td><td>0.007</td><td>0.008</td><td>0.400</td><td>&#x02212;&#x02009;1.798</td><td>0.922</td><td>0.053</td><td/></tr><tr><td>&#x02003;&#x02003;Antihypertensive medication</td><td>0.146</td><td>0.793</td><td>0.855</td><td>0.041</td><td>0.026</td><td>0.117</td><td>&#x02212;&#x02009;5.445</td><td>2.887</td><td>0.061</td><td/></tr><tr><td colspan="11">Multiple linear regression model</td></tr><tr><td rowspan="2"/><td colspan="3">Blood urea nitrogen</td><td colspan="3">Creatinine</td><td colspan="3">Estimated glomerular filtration rate</td><td/></tr><tr><td>Partial regression coefficient</td><td>Standard error</td><td><italic>P</italic> value</td><td>Partial regression coefficient</td><td>Standard error</td><td><italic>P</italic> value</td><td>Partial regression coefficient</td><td>Standard error</td><td><italic>P</italic> value</td><td>Variance inflation factor</td></tr><tr><td colspan="11">&#x02003;Mt5178C</td></tr><tr><td>&#x02003;&#x02003;Age</td><td>0.722</td><td>0.346</td><td>0.038</td><td>0.018</td><td>0.011</td><td>0.109</td><td>&#x02212;&#x02009;5.811</td><td>1.226</td><td>&#x0003c;&#x02009;0.001</td><td>1.108</td></tr><tr><td>&#x02003;&#x02003;Body mass index</td><td>&#x02212;&#x02009;0.085</td><td>0.086</td><td>0.321</td><td>0.004</td><td>0.003</td><td>0.206</td><td>&#x02212;&#x02009;0.368</td><td>0.304</td><td>0.228</td><td>1.034</td></tr><tr><td>&#x02003;&#x02003;Smoking habit</td><td>&#x02212;&#x02009;0.612</td><td>0.346</td><td>0.079</td><td>0.001</td><td>0.011</td><td>0.951</td><td>0.036</td><td>1.226</td><td>0.976</td><td>1.059</td></tr><tr><td>&#x02003;&#x02003;Alcohol consumption</td><td>0.056</td><td>0.321</td><td>0.863</td><td>&#x02212;&#x02009;0.007</td><td>0.010</td><td>0.528</td><td>1.126</td><td>1.138</td><td>0.323</td><td>1.069</td></tr><tr><td>&#x02003;&#x02003;Green tea consumption</td><td>0.136</td><td>0.222</td><td>0.542</td><td>0.000</td><td>0.004</td><td>0.951</td><td>&#x02212;&#x02009;0.296</td><td>0.786</td><td>0.707</td><td>1.073</td></tr><tr><td>&#x02003;&#x02003;Antihypertensive medication</td><td>&#x02212;&#x02009;0.733</td><td>0.623</td><td>0.241</td><td>0.010</td><td>0.020</td><td>0.615</td><td>&#x02212;&#x02009;0.916</td><td>2.206</td><td>0.678</td><td>1.109</td></tr><tr><td colspan="11">&#x02003;Mt5178A</td></tr><tr><td>&#x02003;&#x02003;Age</td><td>1.370</td><td>0.375</td><td>&#x0003c;&#x02009;0.001</td><td>&#x02212;&#x02009;0.012</td><td>0.013</td><td>0.308</td><td>&#x02212;&#x02009;2.653</td><td>1.359</td><td>0.053</td><td>1.194</td></tr><tr><td>&#x02003;&#x02003;Body mass index</td><td>0.052</td><td>0.101</td><td>0.605</td><td>0.002</td><td>0.003</td><td>0.596</td><td>&#x02212;&#x02009;0.284</td><td>0.365</td><td>0.438</td><td>1.027</td></tr><tr><td>&#x02003;&#x02003;Smoking habit</td><td>&#x02212;&#x02009;0.414</td><td>0.357</td><td>0.248</td><td>&#x02212;&#x02009;0.020</td><td>0.012</td><td>0.096</td><td>1.863</td><td>1.293</td><td>0.152</td><td>1.036</td></tr><tr><td>&#x02003;&#x02003;Alcohol consumption</td><td>&#x02212;&#x02009;0.126</td><td>0.378</td><td>0.739</td><td>&#x02212;&#x02009;0.025</td><td>0.013</td><td>0.052</td><td>3.580</td><td>1.369</td><td>0.010</td><td>1.042</td></tr><tr><td>&#x02003;&#x02003;Green tea consumption</td><td>&#x02212;&#x02009;0.306</td><td>0.259</td><td>0.240</td><td>0.005</td><td>0.009</td><td>0.603</td><td>&#x02212;&#x02009;0.679</td><td>0.939</td><td>0.471</td><td>1.122</td></tr><tr><td>&#x02003;&#x02003;Antihypertensive medication</td><td>&#x02212;&#x02009;0.756</td><td>0.805</td><td>0.349</td><td>0.043</td><td>0.027</td><td>0.115</td><td>&#x02212;&#x02009;3.146</td><td>2.916</td><td>0.282</td><td>1.106</td></tr></tbody></table><table-wrap-foot><p>Variance inflation factor shows the value when all covariates are in the multiple linear regression model</p></table-wrap-foot></table-wrap></p><p id="Par26">In the case of reduced eGFR defined as &#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>, for subjects with Mt5178C genotype, reduced eGFR was dependent on aging (<italic>P</italic> for trend &#x0003c;&#x02009;0.001) (Table <xref rid="Tab3" ref-type="table">3</xref>). The OR for reduced eGFR was significantly higher in those aged 50&#x02013;59 and &#x02265;&#x02009;60&#x02009;years than in those aged &#x0003c;&#x02009;50&#x02009;years (OR = 3.100, 95% confidence interval (CI) 1.509&#x02013;6.370, <italic>P</italic> = 0.002 and OR = 5.007, 95% CI 1.863&#x02013;13.45, <italic>P</italic> = 0.001, respectively). After adjusting for smoking status and alcohol consumption, reduced eGFR was dependent on aging (<italic>P</italic> for trend = 0.001). The adjusted OR for reduced eGFR was significantly higher in those aged 50&#x02013;59 and &#x02265;&#x02009;60&#x02009;years than in those aged &#x0003c;&#x02009;50&#x02009;years (adjusted OR = 3.086, 95% CI 1.497&#x02013;6.362, <italic>P</italic> = 0.002 and adjusted OR = 4.206, 95% CI 1.506&#x02013;11.75, <italic>P</italic> = 0.006, respectively). In contrast, for subjects with Mt5178A genotype, no significant statistical association between aging and reduced eGFR was observed. In the case of reduced eGFR defined as &#x0003c;&#x02009;75&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>, reduced eGFR was dependent on aging in Mt5178C and Mt5178A genotypic men (<italic>P</italic> for trend &#x0003c;&#x02009;0.001 and <italic>P</italic> for trend = 0.002, respectively). For subjects with Mt5178C genotype, the OR for reduced eGFR was significantly higher in those aged 50&#x02013;59 and &#x02265;&#x02009;60&#x02009;years than in those aged &#x0003c;&#x02009;50&#x02009;years (OR = 3.937, 95% CI 1.832&#x02013;8.461, <italic>P</italic> &#x0003c; 0.001 and OR = 8.391, 95% CI 3.596&#x02013;19.58, <italic>P</italic> &#x0003c; 0.001, respectively). For those with Mt5178A genotype, the OR for reduced eGFR was significantly higher only in those aged &#x02265;&#x02009;60&#x02009;years than in those aged &#x0003c;&#x02009;50&#x02009;years (OR = 4.343, 95% CI 1.733&#x02013;10.89, <italic>P</italic> = 0.002). After adjusting for smoking status and alcohol consumption, in both Mt5178C and Mt5178A genotypic men, reduced eGFR was also dependent on aging (<italic>P</italic> for trend &#x0003c;&#x02009;0.001 and <italic>P</italic> for trend = 0.014, respectively). For subjects with Mt5178C genotype, the adjusted OR for reduced eGFR was significantly higher in those aged 50&#x02013;59 and &#x02265;&#x02009;60&#x02009;years than in those aged &#x0003c;&#x02009;50&#x02009;years (adjusted OR = 3.955, 95% CI 1.821&#x02013;8.591, <italic>P</italic> &#x0003c; 0.001 and adjusted OR = 7.961, 95% CI 3.261&#x02013;19.43, <italic>P</italic> &#x0003c; 0.001, respectively). For subjects with Mt5178A genotype, the adjusted OR for reduced eGFR was significantly higher in those aged &#x02265;&#x02009;60&#x02009;years than in those aged &#x0003c;&#x02009;50&#x02009;years (adjusted OR = 3.667, 95% CI 1.355&#x02013;9.921, <italic>P</italic> = 0.011).
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Odds ratios (ORs) and 95% confidence intervals (CIs) for reduced eGFR (&#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup> or &#x0003c;&#x02009;75&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>) by Mt5178 C/A genotype and age group</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Genotype and age group</th><th colspan="2">Renal function</th><th>OR (95% CI)</th><th>Adjusted OR<sup>&#x02020;</sup> (95% CI)</th></tr></thead><tbody><tr><td/><td>eGFR &#x02265;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup></td><td>eGFR &#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup></td><td/><td/></tr><tr><td>Mt5178C</td><td><italic>N</italic> (%)</td><td><italic>N</italic> (%)</td><td/><td/></tr><tr><td>&#x02003;&#x0003c;&#x02009;50&#x02009;years</td><td>22 (34.9)</td><td>41 (65.1)</td><td>1 (reference)</td><td>1 (reference)</td></tr><tr><td>&#x02003;50&#x02013;59&#x02009;years</td><td>18 (14.8)</td><td>104 (85.2)</td><td>3.100 (1.509&#x02013;6.370)**</td><td>3.086 (1.497&#x02013;6.362)**</td></tr><tr><td>&#x02003;&#x02265;&#x02009;60&#x02009;years</td><td>6 (9.7)</td><td>56 (90.3)</td><td>5.007 (1.863&#x02013;13.45)**</td><td>4.206 (1.506&#x02013;11.75)*</td></tr><tr><td/><td/><td/><td><italic>P</italic> for trend &#x0003c;&#x02009;0.001</td><td><italic>P</italic> for trend = 0.001</td></tr><tr><td>Mt5178A</td><td><italic>N</italic> (%)</td><td><italic>N</italic> (%)</td><td/><td/></tr><tr><td>&#x02003;&#x0003c;&#x02009;50&#x02009;years</td><td>16 (29.6)</td><td>38 (70.4)</td><td>1 (reference)</td><td>1 (reference)</td></tr><tr><td>&#x02003;50&#x02013;59&#x02009;years</td><td>18 (27.7)</td><td>47 (72.3)</td><td>1.099 (0.495&#x02013;2.441)</td><td>1.053 (0.464&#x02013;2.391)</td></tr><tr><td>&#x02003;&#x02265;&#x02009;60&#x02009;years</td><td>5 (13.2)</td><td>33 (86.8)</td><td>2.779 (0.918&#x02013;8.409)</td><td>2.070 (0.617&#x02013;6.946)</td></tr><tr><td/><td/><td/><td><italic>P</italic> for trend = 0.090</td><td><italic>P</italic> for trend = 0.179</td></tr><tr><td/><td>eGFR &#x02265;&#x02009;75&#x02009;mL/min/1.73&#x02009;m<sup>2</sup></td><td>eGFR &#x0003c;&#x02009;75&#x02009;mL/min/1.73&#x02009;m<sup>2</sup></td><td/><td/></tr><tr><td>Mt5178C</td><td><italic>N</italic> (%)</td><td><italic>N</italic> (%)</td><td/><td/></tr><tr><td>&#x02003;&#x0003c;&#x02009;50&#x02009;years</td><td>53 (84.1)</td><td>10 (15.9)</td><td>1 (reference)</td><td>1 (reference)</td></tr><tr><td>&#x02003;50&#x02013;59&#x02009;years</td><td>70 (57.4)</td><td>52 (42.6)</td><td>3.937 (1.832&#x02013;8.461)***</td><td>3.955 (1.821&#x02013;8.591)***</td></tr><tr><td>&#x02003;&#x02265;&#x02009;60&#x02009;years</td><td>24 (38.7)</td><td>38 (61.3)</td><td>8.391 (3.596&#x02013;19.58)***</td><td>7.961 (3.261&#x02013;19.43)***</td></tr><tr><td/><td/><td/><td><italic>P</italic> for trend &#x0003c;&#x02009;0.001</td><td><italic>P</italic> for trend &#x0003c;&#x02009;0.001</td></tr><tr><td>Mt5178A</td><td><italic>N</italic> (%)</td><td><italic>N</italic> (%)</td><td/><td/></tr><tr><td>&#x02003;&#x0003c;&#x02009;50&#x02009;years</td><td>43 (79.6)</td><td>11 (20.4)</td><td>1 (reference)</td><td>1 (reference)</td></tr><tr><td>&#x02003;50&#x02013;59&#x02009;years</td><td>44 (67.7)</td><td>21 (32.3)</td><td>1.866 (0.804&#x02013;4.330)</td><td>1.713 (0.712&#x02013;4.126)</td></tr><tr><td>&#x02003;&#x02265;&#x02009;60&#x02009;years</td><td>18 (47.4)</td><td>20 (52.6)</td><td>4.343 (1.733&#x02013;10.89)**</td><td>3.667 (1.355&#x02013;9.921)*</td></tr><tr><td/><td/><td/><td><italic>P</italic> for trend = 0.002</td><td><italic>P</italic> for trend = 0.014</td></tr></tbody></table><table-wrap-foot><p>&#x02020;OR adjusted for smoking status and alcohol consumption</p><p>*<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.005, ***<italic>P</italic> &#x0003c; 0.001</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec8"><title>Discussion</title><p id="Par27">In this exploratory cross-sectional study, we found that longevity-associated Mt5178 C/A polymorphism modifies the effect of aging on renal function. In simple linear regression analysis, a significant negative association between aging and eGFR was observed in both Mt5178C and Mt5178A genotypic men. Nevertheless, in multiple linear regression analysis, namely after adjustment, a significant effect of aging on reduced eGFR was observed only in men with Mt5178C genotype. In the case of reduced eGFR defined as &#x0003c;&#x02009;75&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>, reduced eGFR was dependent on aging in both Mt5178C and Mt5178A genotypic men. However, in the case of reduced eGFR defined as &#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>, reduced eGFR was dependent on aging only in men with Mt5178C genotype.</p><p id="Par28">There seems to be a genetic merit of Mt5178A genotype to lead longevity [<xref ref-type="bibr" rid="CR9">9</xref>]. Individuals with Mt5178A genotype are reportedly resistant to adult-onset diseases, namely hypertension [<xref ref-type="bibr" rid="CR10">10</xref>], diabetes [<xref ref-type="bibr" rid="CR11">11</xref>], circulatory diseases [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>], and Parkinson&#x02019;s disease [<xref ref-type="bibr" rid="CR28">28</xref>]. On the contrary, it is thought to be more arduous for individuals with Mt5178C genotype to realize longevity than those with Mt5178A genotype. The present study shows that physiological aging effect on reduced renal function is more evident in subjects with Mt5178C genotype than in those with Mt5178A genotype. Moreover, age is significantly and negatively associated with pulmonary function, namely forced expiratory volume in 1 s per forced vital capacity, only in men with Mt5178C genotype [<xref ref-type="bibr" rid="CR17">17</xref>]. Considering both renal and pulmonary function, physiological aging seems to be more apparent in Mt5178C genotypic men than in Mt5178A genotypic men.</p><p id="Par29">Based on the information of Mt5178 C/A polymorphism, lifestyle modification has the potential to improve physiological aging of renal function. We previously demonstrated that Mt5178 C/A polymorphism modulates the effect of alcohol consumption [<xref ref-type="bibr" rid="CR15">15</xref>] or green tea consumption [<xref ref-type="bibr" rid="CR16">16</xref>] on renal function. For Mt5178A genotypic men, habitual alcohol consumption reduces the risk of mildly decreased eGFR [<xref ref-type="bibr" rid="CR15">15</xref>]. The risk of mildly decreased eGFR (&#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>) was significantly lower in daily drinkers than in non-drinkers. Conversely, for Mt5178C genotypic men, green tea consumption increases the risk of mildly decreased eGFR [<xref ref-type="bibr" rid="CR16">16</xref>]. The risk of mildly decreased eGFR (&#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>) was significantly higher in subjects who consumed &#x02265;&#x02009;6 cups of green tea per day than in those who consumed &#x02264;&#x02009;1 cup of green tea per day. Previous molecular epidemiological studies on Mt5178 C/A polymorphism have reported gene-environment interactions on the risk of lifestyle-related diseases, namely hypertension [<xref ref-type="bibr" rid="CR10">10</xref>], dyslipidemia [<xref ref-type="bibr" rid="CR29">29</xref>], hyperuricemia [<xref ref-type="bibr" rid="CR22">22</xref>], and liver injury [<xref ref-type="bibr" rid="CR30">30</xref>]. Therefore, Mt5178 C/A genotyping may contribute to the establishment of individualized prevention not only for the physiological aging reduction of renal function but also for lifestyle-related diseases.</p><p id="Par30">The present study demonstrated a significant positive association between aging and BUN levels in both Mt5178C and Mt5178A genotypic men. BUN levels, which have been utilized to evaluate renal function, are affected by nutrient intake [<xref ref-type="bibr" rid="CR31">31</xref>]. Interaction between ND2-237 Leu/Met, namely Mt5178 C/A, polymorphism and &#x003b2;<sub>3</sub>-adrenergic receptor gene 64 (BAR3-64) Trp/Arg polymorphism on nutrient intake was reported [<xref ref-type="bibr" rid="CR32">32</xref>]. BAR3-64 Trp/Trp genotype is the wild type, and BAR3-64 Trp/Arg or BAR3-64 Arg/Arg genotype is the variant type. Individuals with BAR3-64 wild type and Mt5178A genotype intake more carbohydrates and less animal protein than those with BAR3-64 wild type and Mt5178C genotype or those with BAR3-64 variant type, irrespective of Mt5178 C/A genotype. To verify BUN level through the abovementioned gene-gene interaction on eating behavior, a further genetic epidemiological investigation is required.</p><p id="Par31">The underlying physiological mechanisms by which Mt5178 C/A, namely ND2-237 Leu/Met, polymorphism influences the effect of aging on kidney function remain unknown. NADH dehydrogenase, namely mitochondrial complex I, is recognized as the major site to release reactive oxygen species (ROS) in the mitochondria [<xref ref-type="bibr" rid="CR33">33</xref>]. Extrapolation from an experimental animal model [<xref ref-type="bibr" rid="CR34">34</xref>] to humans would suggest that ND2-237Met, deduced from Mt5178A, may suppress ROS production. This postulated suppression of ROS production may bring advantages for individuals with Mt5178A genotype in physiological aging of renal function. However, in contrast to conventional free radical theory in aging, the age-related increase in ROS production is recently thought to be relatively small and may not elucidate physiological changes in the aging process [<xref ref-type="bibr" rid="CR4">4</xref>]. Therefore, further biophysical and biochemical investigations will be required.</p><p id="Par32">This study evaluated only one single nucleotide polymorphism (SNP), namely Mt5178 C/A polymorphism. Longevity-associated Mt5178A genotype, recognized as mitochondrial haplogroup D, controversially contributes to the pathogenesis of early-onset end-stage renal disease [<xref ref-type="bibr" rid="CR7">7</xref>]. Moreover, several SNPs in the mitochondrial displacement loop are potential predictors for CKD [<xref ref-type="bibr" rid="CR8">8</xref>]. In addition to mitochondrial DNA SNPs, several SNPs of nuclear DNA are reportedly associated with CKD [<xref ref-type="bibr" rid="CR35">35</xref>]. Recently, a trans-ancestry meta-analysis of genome-wide association studies of eGFR showed that 264 genetic loci, including 166 newly identified loci, were associated with kidney function [<xref ref-type="bibr" rid="CR36">36</xref>]. Therefore, further genetic surveys will be necessary.</p><p id="Par33">We use two definitions of reduced eGFR. Similar to our previous studies [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] and other molecular epidemiological studies [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], based on Kidney Disease Outcomes Quality Initiative CKD classification [<xref ref-type="bibr" rid="CR26">26</xref>], reduced eGFR is considered to be &#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>. A large-scale population-based survey showed that the prevalence of eGFR &#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup> was 80.6% in Japanese men aged 30&#x02013;69&#x02009;years [<xref ref-type="bibr" rid="CR37">37</xref>]. In this study, the prevalence of eGFR &#x0003c;&#x02009;90&#x02009;mL/min/1.73&#x02009;m<sup>2</sup> was also high, namely 82.4% in Mt5178C genotypic men and 75.2% in Mt5178A genotypic men. Moreover, based on an individual-level meta-analysis of 46 cohort studies [<xref ref-type="bibr" rid="CR27">27</xref>], reduced eGFR is also considered to be &#x0003c;&#x02009;75&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>. Although, the lowest risk of mortality is at a GRF of &#x02265;&#x02009;75&#x02009;mL/min/1.73&#x02009;m<sup>2</sup> for age &#x0003c;&#x02009;55&#x02009;years, that is at GFR of 45&#x02013;104&#x02009;mL/min/1.73&#x02009;m<sup>2</sup> for age &#x02265;&#x02009;65&#x02009;years [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. In our study, the prevalence of moderately decreased eGFR of &#x0003c;&#x02009;60&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>, generally recognized as CKD, was very low in Mt5178C and Mt5178A genotypic men. Therefore, the validity of the two definitions of reduced eGFR adopted in this cross-sectional study is worthy of further deliberation.</p><p id="Par34">As in other molecular epidemiological studies of renal function in the Japanese population [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], the eGFR value was calculated using a three-variable Japanese equation [<xref ref-type="bibr" rid="CR18">18</xref>]. Because this equation includes age as a predictor variable, a negative association between age and eGFR is naturally observed. All eGFR equations, utilized in many epidemiological studies, include age as a predictor variable [<xref ref-type="bibr" rid="CR1">1</xref>]. Therefore, it is difficult to explain outcomes with eGFR across different age groups.</p><p id="Par35">Several crucial limitations of this study should be discussed. First, the study sample was very small. Second, subjects comprised of only men. Third, we inspected only a single population. Precluding chance error in a molecular epidemiological study, it is obligatory for us to examine two or more independent datasets. Fourth, self-selection bias was not controlled. Individuals who visited the hospital for regular medical checkups were more health-conscious than those who did not receive health checkups. Fifth, although the cross-sectional study design can propose causal links, it cannot establish credible causality. Moreover, Chung et al. recommended longitudinal analysis to estimate and predict renal function decline rate with aging [<xref ref-type="bibr" rid="CR38">38</xref>]. To overcome the abovementioned limitations, a prospective cohort study with a larger sample size including several populations is required. Finally, it was inferred from previous reports [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>] that lack of data on diet or physical activity was also a weakness of this study.</p></sec><sec id="Sec9"><title>Conclusions</title><p id="Par36">This exploratory cross-sectional study suggests that Mt5178 C/A polymorphism may modify the effects of aging on renal function in male Japanese health checkup examinees. Aging effects on reduced renal function are thought to be more apparent in subjects with Mt5178C genotype than in those with Mt5178A genotype. In addition to resistance to adult-onset diseases [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], from a physiological viewpoint, individuals with Mt5178A genotype realize longevity more effortlessly than those with Mt5178C genotype. Although the underlying physiological mechanisms have not been elucidated, molecular epidemiological studies on Mt5178 C/A polymorphism may contribute to the understanding of not only the aging kidney but also the physiological aging.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>BAR3-64</term><def><p id="Par5">&#x003b2;<sub>3</sub>-Adrenergic receptor gene 64</p></def></def-item><def-item><term>BMI</term><def><p id="Par6">Body mass index</p></def></def-item><def-item><term>BUN</term><def><p id="Par7">Blood urea nitrogen</p></def></def-item><def-item><term>CI</term><def><p id="Par8">Confidence interval</p></def></def-item><def-item><term>CKD</term><def><p id="Par9">Chronic kidney disease</p></def></def-item><def-item><term>eGFR</term><def><p id="Par10">Estimated glomerular filtration rate</p></def></def-item><def-item><term>GFR</term><def><p id="Par11">Glomerular filtration rate</p></def></def-item><def-item><term>Mt5178</term><def><p id="Par12">Mitochondrial DNA 5178</p></def></def-item><def-item><term>ND2-237</term><def><p id="Par13">NADH dehydrogenase subunit-2 237</p></def></def-item><def-item><term>OR</term><def><p id="Par14">Odds ratio</p></def></def-item><def-item><term>ROS</term><def><p id="Par15">Reactive oxygen species</p></def></def-item><def-item><term>SNP</term><def><p id="Par16">Single nucleotide polymorphism</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank Ms. Yoshiko Abe and Ms. Hiromi Hoshino for their support.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>IO analyzed the data and drafted the manuscript. MI collected the samples. NM assisted with the genotyping. KK and MY carried out the epidemiological survey. HO, TS, TY, AM, and SS assisted in the data analysis and helped with the interpretation of the results. AK designed the study, carried out the epidemiological survey, carried out the genotyping, analyzed the data, and drafted the manuscript. All authors have read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos. 14570355, 18590572, 23500859, and 26350908) and the Chiyoda Mutual Life Foundation.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par37">All participants gave written informed consent before participating in this study. This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Kyorin University School of Medicine.</p></notes><notes><title>Consent for publication</title><p id="Par38">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par39">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denic</surname><given-names>A</given-names></name><name><surname>Glassock</surname><given-names>RJ</given-names></name><name><surname>Rule</surname><given-names>AD</given-names></name></person-group><article-title>Structural and functional changes with the aging kidney</article-title><source>Adv Chronic Kidney Dis.</source><year>2016</year><volume>23</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1053/j.ackd.2015.08.004</pub-id><pub-id pub-id-type="pmid">26709059</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hommos</surname><given-names>MS</given-names></name><name><surname>Glassock</surname><given-names>RJ</given-names></name><name><surname>Rule</surname><given-names>AD</given-names></name></person-group><article-title>Structural and functional changes in human kidneys with healthy aging</article-title><source>J Am Soc Nephrol.</source><year>2017</year><volume>28</volume><fpage>2838</fpage><lpage>2844</lpage><pub-id pub-id-type="doi">10.1681/ASN.2017040421</pub-id><pub-id pub-id-type="pmid">28790143</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Sullivan</surname><given-names>ED</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Ferenbach</surname><given-names>DA</given-names></name></person-group><article-title>Renal aging: cause and consequences</article-title><source>J Am Soc Nephrol.</source><year>2017</year><volume>28</volume><fpage>407</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1681/ASN.2015121308</pub-id><pub-id pub-id-type="pmid">28143966</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bratic</surname><given-names>A</given-names></name><name><surname>Larsson</surname><given-names>NG</given-names></name></person-group><article-title>The role of mitochondria in aging</article-title><source>J Clin Invest.</source><year>2013</year><volume>123</volume><fpage>951</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1172/JCI64125</pub-id><pub-id pub-id-type="pmid">23454757</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emma</surname><given-names>F</given-names></name><name><surname>Montini</surname><given-names>G</given-names></name><name><surname>Parikh</surname><given-names>SM</given-names></name><name><surname>Salviati</surname><given-names>L</given-names></name></person-group><article-title>Mitochondrial dysfunction in inherited renal disease and acute kidney injury</article-title><source>Nat Rev Nephrol.</source><year>2016</year><volume>12</volume><fpage>267</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/nrneph.2015.214</pub-id><pub-id pub-id-type="pmid">26804019</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tin</surname><given-names>A</given-names></name><name><surname>Grams</surname><given-names>ME</given-names></name><name><surname>Ashar</surname><given-names>FN</given-names></name><name><surname>Lane</surname><given-names>JA</given-names></name><name><surname>Rosenberg</surname><given-names>AZ</given-names></name><name><surname>Grove</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Association between mitochondrial DNA copy number in peripheral blood and incident CKD in the atherosclerosis risk in communities study</article-title><source>J Am Soc Nephrol.</source><year>2016</year><volume>27</volume><fpage>2467</fpage><lpage>2473</lpage><pub-id pub-id-type="doi">10.1681/ASN.2015060661</pub-id><pub-id pub-id-type="pmid">26794963</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name></person-group><article-title>Association of mitochondrial haplogroups and mitochondrial DNA copy numbers with end-stage renal disease in a Han population</article-title><source>Mitochondrial DNA A DNA Mapp Seq Anal.</source><year>2017</year><volume>28</volume><fpage>725</fpage><lpage>731</lpage><pub-id pub-id-type="pmid">27159351</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Association of sequence polymorphism in the mitochondrial D-loop with chronic kidney disease</article-title><source>Ren Fail.</source><year>2014</year><volume>36</volume><fpage>781</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.3109/0886022X.2014.890842</pub-id><pub-id pub-id-type="pmid">24576051</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Gong</surname><given-names>JS</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yoneda</surname><given-names>M</given-names></name><name><surname>Yagi</surname><given-names>K</given-names></name></person-group><article-title>Mitochondrial genotype associated with longevity</article-title><source>Lancet.</source><year>1998</year><volume>351</volume><fpage>185</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(05)78211-8</pub-id><pub-id pub-id-type="pmid">9449878</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kokaze</surname><given-names>A</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Matsunaga</surname><given-names>N</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>M</given-names></name><name><surname>Teruya</surname><given-names>K</given-names></name><etal/></person-group><article-title>NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modifies the effects of alcohol consumption on risk for hypertension in middle-aged Japanese men</article-title><source>Hypertens Res.</source><year>2007</year><volume>30</volume><fpage>213</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1291/hypres.30.213</pub-id><pub-id pub-id-type="pmid">17510502</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Taniyama</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Katagiri</surname><given-names>T</given-names></name><name><surname>Ban</surname><given-names>Y</given-names></name></person-group><article-title>Association of the mitochondrial DNA 5178 A/C polymorphism with maternal inheritance and onset of type 2 diabetes in Japanese patients</article-title><source>Exp Clin Endocrinol Diabetes.</source><year>2001</year><volume>109</volume><fpage>361</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1055/s-2001-17407</pub-id><pub-id pub-id-type="pmid">11573146</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukae</surname><given-names>S</given-names></name><name><surname>Aoki</surname><given-names>S</given-names></name><name><surname>Itoh</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>R</given-names></name><name><surname>Nishio</surname><given-names>K</given-names></name><name><surname>Iwata</surname><given-names>T</given-names></name><etal/></person-group><article-title>Mitochondrial 5178A/C genotype is associated with acute myocardial infarction</article-title><source>Circ J.</source><year>2003</year><volume>67</volume><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1253/circj.67.16</pub-id><pub-id pub-id-type="pmid">12520145</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takagi</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Gong</surname><given-names>JS</given-names></name><name><surname>Sone</surname><given-names>T</given-names></name><name><surname>Yokota</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name></person-group><article-title>Association of a 5178C&#x02192;A (Leu237Met) polymorphism in the mitochondrial DNA with a low prevalence of myocardial infarction in Japanese individuals</article-title><source>Atherosclerosis.</source><year>2004</year><volume>175</volume><fpage>281</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2004.03.008</pub-id><pub-id pub-id-type="pmid">15262184</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohkubo</surname><given-names>R</given-names></name><name><surname>Nakagawa</surname><given-names>M</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Kodama</surname><given-names>T</given-names></name><name><surname>Arimura</surname><given-names>K</given-names></name><name><surname>Akiba</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cerebrovascular disorders and genetic polymorphisms: mitochondrial DNA5178C is predominant in cerebrovascular disorders</article-title><source>J Neurol Sci.</source><year>2002</year><volume>198</volume><fpage>31</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/S0022-510X(02)00055-2</pub-id><pub-id pub-id-type="pmid">12039661</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kokaze</surname><given-names>A</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Matsunaga</surname><given-names>N</given-names></name><name><surname>Karita</surname><given-names>K</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Shimada</surname><given-names>N</given-names></name><etal/></person-group><article-title>Combined effect of mitochondrial DNA 5178 C/A polymorphism and alcohol consumption on estimated glomerular filtration rate in male Japanese health check-up examinees: a cross-sectional study</article-title><source>BMC Nephrol.</source><year>2013</year><volume>14</volume><fpage>35</fpage><pub-id pub-id-type="doi">10.1186/1471-2369-14-35</pub-id><pub-id pub-id-type="pmid">23402433</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kokaze</surname><given-names>A</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Matsunaga</surname><given-names>N</given-names></name><name><surname>Karita</surname><given-names>K</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Ohtsu</surname><given-names>T</given-names></name><etal/></person-group><article-title>Unexpected combined effects of NADH dehydrogenase subunit-2 237 Leu/Met polymorphism and green tea consumption on renal function in male Japanese health check-up examinees: a cross-sectional study</article-title><source>J Negat Results Biomed.</source><year>2013</year><volume>12</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/1477-5751-12-17</pub-id><pub-id pub-id-type="pmid">24252463</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kokaze</surname><given-names>A</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Matsunaga</surname><given-names>N</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>M</given-names></name><name><surname>Teruya</surname><given-names>K</given-names></name><etal/></person-group><article-title>Longevity-associated mitochondrial DNA 5178 C/A polymorphism and its interaction with cigarette consumption are associated with pulmonary function in middle-aged Japanese men</article-title><source>J Hum Genet.</source><year>2007</year><volume>52</volume><fpage>680</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1007/s10038-007-0171-0</pub-id><pub-id pub-id-type="pmid">17636359</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>S</given-names></name><name><surname>Imai</surname><given-names>E</given-names></name><name><surname>Horio</surname><given-names>M</given-names></name><name><surname>Yasuda</surname><given-names>Y</given-names></name><name><surname>Tomota</surname><given-names>K</given-names></name><name><surname>Nitta</surname><given-names>K</given-names></name><etal/></person-group><article-title>Revised equations for estimated GFR from serum creatinine in Japan</article-title><source>Am J Kidney Dis.</source><year>2009</year><volume>53</volume><fpage>982</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2008.12.034</pub-id><pub-id pub-id-type="pmid">19339088</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname><given-names>R</given-names></name><name><surname>Kohara</surname><given-names>K</given-names></name><name><surname>Tabara</surname><given-names>Y</given-names></name><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Ohtsuka</surname><given-names>N</given-names></name><name><surname>Kusunoki</surname><given-names>T</given-names></name><etal/></person-group><article-title>An association between body mass index and estimated glomerular filtration rate</article-title><source>Hypertens Res.</source><year>2008</year><volume>31</volume><fpage>1559</fpage><lpage>1564</lpage><pub-id pub-id-type="doi">10.1291/hypres.31.1559</pub-id><pub-id pub-id-type="pmid">18971530</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Zhi</given-names></name><name><surname>Rebholz</surname><given-names>Casey M.</given-names></name><name><surname>Wong</surname><given-names>Eugenia</given-names></name><name><surname>Chen</surname><given-names>Yuan</given-names></name><name><surname>Matsushita</surname><given-names>Kunihiro</given-names></name><name><surname>Coresh</surname><given-names>Josef</given-names></name><name><surname>Grams</surname><given-names>Morgan E.</given-names></name></person-group><article-title>Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC)&#x000a0;Study</article-title><source>American Journal of Kidney Diseases</source><year>2019</year><volume>74</volume><issue>3</issue><fpage>310</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2019.02.015</pub-id><pub-id pub-id-type="pmid">31031087</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyatake</surname><given-names>N</given-names></name><name><surname>Moriyasu</surname><given-names>H</given-names></name><name><surname>Sakano</surname><given-names>N</given-names></name><name><surname>Tada</surname><given-names>S</given-names></name><name><surname>Suzue</surname><given-names>T</given-names></name><name><surname>Hirao</surname><given-names>T</given-names></name></person-group><article-title>Influence of cigarette smoking on estimated glomerular filtration rate (eGFR) in Japanese male workers</article-title><source>Acta Med Okayama.</source><year>2010</year><volume>64</volume><fpage>385</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">21173808</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kokaze</surname><given-names>A</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Matsunaga</surname><given-names>N</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>M</given-names></name><name><surname>Teruya</surname><given-names>K</given-names></name><etal/></person-group><article-title>Longevity-associated NADH dehydrogenase subunit-2 237 Leu/Met polymorphism influences the effects of alcohol consumption on serum uric acid levels in nonobese Japanese men</article-title><source>J Hum Genet.</source><year>2006</year><volume>51</volume><fpage>765</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1007/s10038-006-0018-0</pub-id><pub-id pub-id-type="pmid">16897192</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno</surname><given-names>Y</given-names></name><name><surname>Ishimura</surname><given-names>E</given-names></name><name><surname>Naganuma</surname><given-names>T</given-names></name><name><surname>Kondo</surname><given-names>K</given-names></name><name><surname>Fukushima</surname><given-names>W</given-names></name><name><surname>Mui</surname><given-names>K</given-names></name><etal/></person-group><article-title>Prevalence of and factors associated with chronic kidney disease (CKD) in Japanese subjects without notable chronic diseases, undergoing an annual health checkup</article-title><source>Kidney Blood Press Res.</source><year>2012</year><volume>36</volume><fpage>139</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1159/000341490</pub-id><pub-id pub-id-type="pmid">23095841</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>R</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Nishio</surname><given-names>K</given-names></name><name><surname>Ishida</surname><given-names>Y</given-names></name><name><surname>Kawai</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association between decreased kidney function and endotoxin receptor CD14 C-159&#x02009;T polymorphism among Japanese health check-up examination</article-title><source>Ren Fail.</source><year>2007</year><volume>29</volume><fpage>967</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1080/08860220701641686</pub-id><pub-id pub-id-type="pmid">18067042</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konta</surname><given-names>T</given-names></name><name><surname>Takasaki</surname><given-names>S</given-names></name><name><surname>Ichikawa</surname><given-names>K</given-names></name><name><surname>Emi</surname><given-names>M</given-names></name><name><surname>Toriyama</surname><given-names>S</given-names></name><name><surname>Satoh</surname><given-names>H</given-names></name><etal/></person-group><article-title>The novel and independent association between single-point SNP of NPHP4 gene and renal function in non-diabetic Japanese population: the Takahata study</article-title><source>J Hum Genet.</source><year>2010</year><volume>55</volume><fpage>791</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1038/jhg.2010.113</pub-id><pub-id pub-id-type="pmid">20844548</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>National Kidney Foundation</collab></person-group><article-title>K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification</article-title><source>Am J Kidney Dis.</source><year>2002</year><volume>39</volume><issue>Suppl 1</issue><fpage>S1</fpage><lpage>S266</lpage><pub-id pub-id-type="pmid">11904577</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallan</surname><given-names>SI</given-names></name><name><surname>Matsushita</surname><given-names>K</given-names></name><name><surname>Sang</surname><given-names>Y</given-names></name><name><surname>Mahmoodi</surname><given-names>BK</given-names></name><name><surname>Black</surname><given-names>C</given-names></name><name><surname>Ishani</surname><given-names>A</given-names></name><etal/></person-group><article-title>Chronic Kidney Disease Prognosis Consortium. Age and association of kidney measures with mortality and end-stage renal disease</article-title><source>JAMA.</source><year>2012</year><volume>308</volume><fpage>2349</fpage><lpage>2360</lpage><pub-id pub-id-type="doi">10.1001/jama.2012.16817</pub-id><pub-id pub-id-type="pmid">23111824</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gusdon</surname><given-names>AM</given-names></name><name><surname>Fang</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Mathews</surname><given-names>CE</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Chu</surname><given-names>CT</given-names></name><etal/></person-group><article-title>Association of the mt-ND2 5178A/C polymorphism with Parkinson&#x02019;s disease</article-title><source>Neurosci Lett.</source><year>2015</year><volume>587</volume><fpage>98</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2014.12.005</pub-id><pub-id pub-id-type="pmid">25511548</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname><given-names>T</given-names></name><name><surname>Kokaze</surname><given-names>A</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Matsunaga</surname><given-names>N</given-names></name><name><surname>Karita</surname><given-names>K</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><etal/></person-group><article-title>Joint effect of longevity-associated mitochondrial DNA 5178 C/A polymorphism and alcohol consumption on risk of hyper-LDL cholesterolemia in middle-aged Japanese men</article-title><source>Lipids Health Dis.</source><year>2011</year><volume>10</volume><fpage>105</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-10-105</pub-id><pub-id pub-id-type="pmid">21702983</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kokaze</surname><given-names>A</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><name><surname>Matsunaga</surname><given-names>N</given-names></name><name><surname>Karita</surname><given-names>K</given-names></name><name><surname>Ochiai</surname><given-names>H</given-names></name><etal/></person-group><article-title>Mitochondrial DNA 5178 C/A polymorphism modulates the effects of coffee consumption on elevated levels of serum liver enzymes in male Japanese health check-up examinees: an exploratory cross-sectional study</article-title><source>J Physiol Anthropol.</source><year>2016</year><volume>35</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/s40101-016-0098-2</pub-id><pub-id pub-id-type="pmid">27260124</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ran</surname><given-names>J</given-names></name><name><surname>Urea</surname><given-names>JT</given-names></name></person-group><source>Subcell Biochem.</source><year>2014</year><volume>73</volume><fpage>7</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1007/978-94-017-9343-8_2</pub-id><pub-id pub-id-type="pmid">25298336</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoyama</surname><given-names>M</given-names></name><name><surname>Shidoji</surname><given-names>Y</given-names></name><name><surname>Saimei</surname><given-names>M</given-names></name><name><surname>Tsunawake</surname><given-names>N</given-names></name><name><surname>Ichinose</surname><given-names>M</given-names></name></person-group><article-title>Phenotypic linkage between single-nucleotide polymorphism of &#x003b2;<sub>3</sub>-adrenergic receptor gene and NADH dehydrogenase subunit-2 gene, with special reference to eating behavior</article-title><source>Biochem Biophys Res Commun.</source><year>2003</year><volume>309</volume><fpage>261</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2003.08.002</pub-id><pub-id pub-id-type="pmid">12943691</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wirth</surname><given-names>C</given-names></name><name><surname>Brandt</surname><given-names>U</given-names></name><name><surname>Hunte</surname><given-names>C</given-names></name><name><surname>Zickermann</surname><given-names>V</given-names></name></person-group><article-title>Structure and function of mitochondrial complex I</article-title><source>Biochim Biophys Acta.</source><year>2016</year><volume>1857</volume><fpage>902</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1016/j.bbabio.2016.02.013</pub-id><pub-id pub-id-type="pmid">26921811</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gusdon</surname><given-names>AM</given-names></name><name><surname>Votyakova</surname><given-names>TV</given-names></name><name><surname>Mathews</surname><given-names>CE</given-names></name></person-group><article-title><italic>mt-Nd2</italic><sup><italic>a</italic></sup> suppresses reactive oxygen species production by mitochondrial complexes I and III</article-title><source>J Biol Chem.</source><year>2008</year><volume>83</volume><fpage>10690</fpage><lpage>10697</lpage><pub-id pub-id-type="doi">10.1074/jbc.M708801200</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>Y</given-names></name><name><surname>Imaizumi</surname><given-names>T</given-names></name><name><surname>Ando</surname><given-names>M</given-names></name><name><surname>Nakatochi</surname><given-names>M</given-names></name><name><surname>Yasuda</surname><given-names>Y</given-names></name><name><surname>Honda</surname><given-names>H</given-names></name><etal/></person-group><article-title>Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: a cross-sectional study in Japanese male workers</article-title><source>PLoS One.</source><year>2017</year><volume>12</volume><fpage>e0185476</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0185476</pub-id><pub-id pub-id-type="pmid">29016630</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wuttke</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Sieber</surname><given-names>KB</given-names></name><name><surname>Feitosa</surname><given-names>MF</given-names></name><name><surname>Gorski</surname><given-names>M</given-names></name><etal/></person-group><article-title>A catalog of genetic loci associated with kidney function from analyses of a million individuals</article-title><source>Nat Genet.</source><year>2019</year><volume>51</volume><fpage>957</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0407-x</pub-id><pub-id pub-id-type="pmid">31152163</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>E</given-names></name><name><surname>Horio</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Iseki</surname><given-names>K</given-names></name><name><surname>Yamagata</surname><given-names>K</given-names></name><name><surname>Hara</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prevalence of chronic kidney disease in the Japanese general population</article-title><source>Clin Exp Nephrol.</source><year>2009</year><volume>13</volume><fpage>621</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1007/s10157-009-0199-x</pub-id><pub-id pub-id-type="pmid">19513802</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>DJ</given-names></name><name><surname>Hand</surname><given-names>A</given-names></name><name><surname>Young</surname><given-names>P</given-names></name><name><surname>Vaidyanathan</surname><given-names>J</given-names></name><name><surname>Sahajwalla</surname><given-names>C</given-names></name></person-group><article-title>Kidney function changes with aging in adults: comparison between cross-sectional and longitudinal data analyses in renal function assessment</article-title><source>Biopharm Drug Dispos.</source><year>2015</year><volume>36</volume><fpage>613</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1002/bdd.1988</pub-id><pub-id pub-id-type="pmid">26301459</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>MC</given-names></name><name><surname>Hwang</surname><given-names>SJ</given-names></name><name><surname>Massaro</surname><given-names>JM</given-names></name><name><surname>Jacques</surname><given-names>PF</given-names></name><name><surname>Fox</surname><given-names>CS</given-names></name><name><surname>Chu</surname><given-names>AY</given-names></name></person-group><article-title>Lifestyle factors and indices of kidney function in the Framingham Heart Study</article-title><source>Am J Nephrol.</source><year>2015</year><volume>41</volume><fpage>267</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1159/000430868</pub-id><pub-id pub-id-type="pmid">25998023</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>MS</given-names></name><name><surname>Sevick</surname><given-names>MA</given-names></name><name><surname>Richardson</surname><given-names>CR</given-names></name><name><surname>Fried</surname><given-names>LF</given-names></name><name><surname>Arena</surname><given-names>VC</given-names></name><name><surname>Kriska</surname><given-names>AM</given-names></name></person-group><article-title>Association between physical activity and kidney function: National Health and Nutrition Examination Survey</article-title><source>Med Sci Sports Exerc.</source><year>2011</year><volume>43</volume><fpage>1457</fpage><lpage>1464</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e31820c0130</pub-id><pub-id pub-id-type="pmid">21200336</pub-id></element-citation></ref></ref-list></back></article>